O(6)-Benzylguanine in Treating Patients With Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 19, 1997

Primary Completion Date

February 20, 2003

Study Completion Date

January 1, 2009

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

O6-benzylguanine

Trial Locations (9)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

94143-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

02115

Dana-Farber Cancer Institute, Boston

48109-0752

University of Michigan Comprehensive Cancer Center, Ann Arbor

15213-3489

University of Pittsburgh Cancer Institute, Pittsburgh

75235-9154

Simmons Cancer Center - Dallas, Dallas

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00002971 - O(6)-Benzylguanine in Treating Patients With Malignant Glioma | Biotech Hunter | Biotech Hunter